title: Elevated interferon-gamma in CNS inflammatory disease: a potential complication for bone marrow reconstitution in MS.
abstract: Bone marrow transplantation (BMT) is increasingly used to treat Multiple Sclerosis (MS) a CNS inflammatory disease with elevated CNS and systemic IFNgamma levels. We wished to determine the effect of IFNgamma on BM graft survival in a transgenic mouse model for chronic MS. BM transplantation into transgenic mice which express elevated levels of IFNgamma in the CNS was unsuccessful. By contrast, there was 100% survival of even fully allogeneic, T-depleted transplants to transgenics that over express TNFalpha in the CNS, using the same MBP promoter. IFNgamma was detectable in spleen of irradiated mice but levels were higher in IFNgamma transgenics. BM transplantation into IFNgamma-deficient recipients also had a high failure rate. Transplants of BM from mice lacking expression of IFNgamma-receptor failed, whereas IFNgamma-deficient grafts survived, suggesting that IFNgamma response status of the graft can also positively influence survival. IFNgamma therefore has a dual role in BM transplantation and the outcome will depend on relative levels of cytokine expression.
authors.affiliation: Neuroimmunology Unit, Montreal Neurological Institute, McGill University, 3801 University, Quebec, H3A 2B4, Montreal, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Hassan-Zahraee
authors.forename: E H
authors.initials: EH
authors.lastname: Tran
authors.forename: L
authors.initials: L
authors.lastname: Bourbonnière
authors.forename: T
authors.initials: T
authors.lastname: Owens
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D002490:Central Nervous System / Q000378:metabolism / Q000473:pathology; D002493:Central Nervous System Diseases / Q000378:metabolism* / Q000473:pathology / Q000628:therapy*; D005260:Female; D015870:Gene Expression; D006084:Graft Rejection; D006085:Graft Survival; D007249:Inflammation / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D007371:Interferon-gamma / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D008822:Mice, Transgenic; D009103:Multiple Sclerosis / Q000378:metabolism / Q000628:therapy*; D004676:Myelin Basic Protein / Q000235:genetics; D011401:Promoter Regions, Genetic / Q000235:genetics; D017471:Receptors, Interferon / Q000235:genetics / Q000378:metabolism; D013047:Specific Pathogen-Free Organisms; D013154:Spleen / Q000378:metabolism; D015996:Survival Rate; D019076:Transgenes / Q000235:genetics; D019737:Transplants; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000378:metabolism; D000096743:Interferon gamma Receptor
chemical_list: D007371:Interferon-gamma; D004676:Myelin Basic Protein; D017471:Receptors, Interferon; D014409:Tumor Necrosis Factor-alpha; D000096743:Interferon gamma Receptor